Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Goeppingen

5 clinical trials in Goeppingen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Goeppingen at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Goeppingen

Open in trial search

Non-small cell lung cancer stage IV+2

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Migraine

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum, Neurotoxin Serotype A/B
  • Sponsor:Ipsen Innovation

Back pain

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dronabinol
  • Sponsor:Vertanical GmbH

Migraine

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Colon cancer stage II+1

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Technische Universitaet Dresden

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Goeppingen

What the registry says about research in the country

01 Oncology Research

Investigating innovative approaches in colon cancer treatment through the CIRCULATE study, focusing on adjuvant therapy effectiveness in stage II patients.

  • Disease-free survival evaluation
  • Circulating tumor DNA analysis
  • Post-resection treatment optimization

This research aims to improve treatment decisions for colorectal cancer patients based on molecular markers.

02 Neurology Studies

Evaluating the effectiveness of rimegepant for migraine prevention in patients who haven't responded well to traditional preventive treatments.

  • Migraine prevention protocols
  • Treatment-resistant cases
  • Long-term efficacy assessment

The research focuses on providing alternative solutions for patients with challenging migraine conditions.

03 Pain Management Research

Exploring the effectiveness of VER-01 in treating chronic non-specific low back pain, particularly for patients who haven't found relief with standard treatments.

  • Dose-response optimization
  • Alternative pain management
  • Treatment resistance solutions

This study aims to provide new options for patients with persistent back pain conditions.

Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.